Circulating miRNAs in cancer: from detection to therapy.
about
MicroRNAs in glioblastoma multiforme pathogenesis and therapeuticsEmerging Role of miRNAs in the Drug Resistance of Gastric CancerCirculating microRNAs as Potential Biomarkers in Non-Alcoholic Fatty Liver Disease and Hepatocellular CarcinomaLncRNA HOTAIR: A master regulator of chromatin dynamics and cancerExosomic microRNAs in the Tumor MicroenvironmentRole of DNA methylation in renal cell carcinomaNon-invasive approaches to monitor EGFR-TKI treatment in non-small-cell lung cancerMicroRNA-153 acts as a prognostic marker in gastric cancer and its role in cell migration and invasionmiR-199a and miR-497 Are Associated with Better Overall Survival due to Increased Chemosensitivity in Diffuse Large B-Cell Lymphoma Patients.Exosomes in cancer: small particle, big player.Exosomes derived from miR-122-modified adipose tissue-derived MSCs increase chemosensitivity of hepatocellular carcinoma.A Circulating microRNA Signature Predicts Age-Based Development of Lymphoma.Overexpression of the long non-coding RNA PVT1 is correlated with leukemic cell proliferation in acute promyelocytic leukemia.Identification of plasma microRNA profiles for primary resistance to EGFR-TKIs in advanced non-small cell lung cancer (NSCLC) patients with EGFR activating mutationExosomes as nanocarriers for systemic delivery of the Helicobacter pylori virulence factor CagA.miR-15b and miR-21 as Circulating Biomarkers for Diagnosis of GliomaGenome-wide screen identified let-7c/miR-99a/miR-125b regulating tumor progression and stem-like properties in cholangiocarcinomaRETRACTED: Decreased expression of the long noncoding RNA LINC00261 indicate poor prognosis in gastric cancer and suppress gastric cancer metastasis by affecting the epithelial-mesenchymal transition.Comprehensive evaluation of serum microRNAs as biomarkers in multiple sclerosisPotential role of exosome-associated microRNA panels and in vivo environment to predict drug resistance for patients with multiple myeloma.Circulating microRNAs as diagnostic and prognostic tools for hepatocellular carcinoma.Enhancing the pharmacokinetic/pharmacodynamic properties of therapeutic nucleotides using lipid nanoparticle systems.Understanding the cancer cell phenotype beyond the limitations of current omics analyses.Knockdown of long non-coding RNA HOXD-AS1 inhibits gastric cancer cell growth via inactivating the JAK2/STAT3 pathway.mTOR inhibitors in urinary bladder cancer.Epigenetics: new possibilities for drug discovery.A new function for miRNAs as regulators of autophagy.Evaluating the prognostic value of miR-148/152 family in cancers: based on a systemic review of observational studies.The potential of circulating cell-free RNA as a cancer biomarker: challenges and opportunities.What is the potential of epigenetics in drug development?Exosomes-Based Biomarkers for the Prognosis of Cardiovascular Diseases.Small non-coding RNA and cancer.Circulating miR-148/152 family as potential biomarkers in hepatocellular carcinoma.
P2860
Q26747273-D5C85F77-FE95-4432-905F-8D38BB842C22Q26752006-CA31FB6D-AE44-49F8-89B1-43D92A486D84Q26767346-0364A028-9A5E-4DBF-8337-87725ED1868EQ26799778-19B65FE4-197D-4051-8915-49458F833F5CQ26799945-0B679F45-200A-4E8E-9724-2D1E6F0C481EQ26801268-3A1DE29F-D9B1-4C11-AB66-3308F43ED84BQ26801357-0E6D7EC9-6DCF-4487-BBB0-64228D5F1F7AQ35067540-EDA39601-B0C1-4B6C-BC52-49BE969D8FB1Q35739550-5236BA88-0C62-4FCD-B86A-43E722CC82B9Q35834473-A22DA173-702C-4801-BCB1-47CD325BA8DDQ36232448-165149D9-FF59-41DB-9C1C-0AD80E46B4AAQ36255792-50A39992-01A6-431E-ABDA-079BC66086D9Q36259132-A1FA5403-B1A3-4DF4-9766-BE669B76EE87Q36276264-D59D849E-2AAF-46FE-98BF-8B6F7EF8F6CDQ36438386-C45543BD-A63B-4650-9316-EB85384A18C6Q36608190-2DD09E1E-4DE5-4A21-836E-BDF0E31932FDQ37064043-14E4AC2B-4BAC-45BE-8C9C-7B61610505DEQ37113234-274DCD25-9CFC-4EDD-826B-A170AC33A470Q37201031-490D5B73-6F18-41EA-B6E0-5717121259ECQ37327618-D84C98ED-B91A-4616-8CE2-C6E134B69F58Q38588428-18253FEB-7E58-47A3-B399-7C77D4896334Q38591825-80B5F036-C858-4F86-B88D-A462B8B12E97Q38595074-E462A474-1374-4C20-97D6-44C0D95E631BQ38704737-9995D30A-A677-4F7D-B432-4D6D66A6B104Q38737064-0617745F-72F2-4808-8658-94CBCBCCE94AQ38737292-59D98873-7829-427C-A504-4AC3CF9995F9Q38783633-CF50BB56-9FB2-40C5-BD27-AE060606D2F3Q47120865-1A0A412D-18F6-42DD-BC18-A36DDCB4C9F3Q47201290-74FDDD2B-E9F6-4CC5-8907-30DA1EE15152Q48539090-49608182-4120-4966-96CF-E1DB32EAA8DEQ49942926-DE352825-AFCA-43EE-8392-99BFFA6E0075Q51031900-4D1E6687-99F5-40BB-9D69-28BAF0D98668Q53289839-2880C37E-E1C7-48C8-AAA8-1646B121E51D
P2860
Circulating miRNAs in cancer: from detection to therapy.
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Circulating miRNAs in cancer: from detection to therapy.
@ast
Circulating miRNAs in cancer: from detection to therapy.
@en
Circulating miRNAs in cancer: from detection to therapy.
@nl
type
label
Circulating miRNAs in cancer: from detection to therapy.
@ast
Circulating miRNAs in cancer: from detection to therapy.
@en
Circulating miRNAs in cancer: from detection to therapy.
@nl
prefLabel
Circulating miRNAs in cancer: from detection to therapy.
@ast
Circulating miRNAs in cancer: from detection to therapy.
@en
Circulating miRNAs in cancer: from detection to therapy.
@nl
P2860
P1476
Circulating miRNAs in cancer: from detection to therapy.
@en
P2093
Wen-Tao Wang
Yue-Qin Chen
P2860
P2888
P356
10.1186/S13045-014-0086-0
P5008
P577
2014-12-05T00:00:00Z
P5875
P6179
1040075078